News Archive

Returning individual research results to clinical study participants has not historically been the norm, even for participants with abnormal findings. The paradigm, though, is shifting, with return of results becoming not only a scientific responsibility but also an ethical imperative. However, best practices haven’t been established yet. A team of Duke researchers led by Svati H. Shah, MD, MS, Ursula Geller Distinguished Professor of Research in Cardiovascular Diseases, and Neha Pagidipati, MD, MPH, associate professor of medicine, have developed a model using the Project Baseline Health Study (PBHS) for how to effectively communicate results to patients and help empower them towards their health and medical choices. The study also detailed the large number of abnormal results that were returned to participants, highlighting the need to consider these processes early in study design. Results were published in the American Journal of Medicine Open.

Data Coordinating Centers (DCCs) are essential to the success of large clinical research studies.

Experts from the Duke Clinical Research Institute (DCRI) presented the latest research and provided expert insights at the annual meeting of the Heart Failure Association of the European Society of Cardiology, May 17-20 in Belgrade, Serbia.

DCRI Accomplishments showcases the publications, awards, and other achievements of our faculty members. Each quarter, a new collection will highlight the most recent accomplishments.

Faculty from the Duke Clinical Research Institute (DCRI) shared new research and offered expert perspectives on emerging issues and advancements in cardiovascular care as part of more than 45 sessions during the American College of Cardiology (ACC) Scientific Sessions, held March 29-31 in Chicago.

Five years after the start of the COVID-19 pandemic, the research community is reflecting on the historic research response to understand the disease and develop diagnostics, ther

Leading experts recently explored how generative AI could revolutionize clinical research through automated documentation and enhanced trial efficiency. Their findings, published in JACC: Advances, outline crucial steps for successful AI integration while addressing technical, ethical, and regulatory challenges to ensure more inclusive and equitable research outcomes.

A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit in taking metformin at a titrated dosage of 1,500 mg pe

The Duke Clinical Research Institute (DCRI) has launched its new podcast, "Beyond the Endpoint," aimed at demystifying clinical research